This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of California. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- La Jolla, CA (US) (2019)
- San Diego, CA (US) (2021)
Company Filing History:
Years Active: 2019-2021
Title: The Innovative Contributions of Phillip Kyriakakis
Introduction
Phillip Kyriakakis is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biosynthesis and nucleic acid assembly. With a total of 2 patents, his work is recognized for its innovative approaches and practical applications.
Latest Patents
Kyriakakis's latest patents include a "System and method for biosynthesis" and "Solid phase sequence-independent nucleic acid assembly." The first patent focuses on methods, systems, and devices for the in vivo production of metabolites in foreign cells. This involves the use of ferredoxin dependent enzymes and a ferredoxin/ferredoxin-NADP reductase system. The second patent outlines methods for assembling nucleic acid fragments in a sequence-independent manner. This process includes annealing nucleic acid fragments onto a solid phase and ligating them through end-to-end ligation.
Career Highlights
Phillip Kyriakakis is affiliated with the University of California, where he continues to advance research in his areas of expertise. His innovative work has garnered attention in the scientific community, contributing to advancements in biotechnology and molecular biology.
Collaborations
Kyriakakis has collaborated with notable colleagues such as Todd Prentice Coleman and Marianne Catanho. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Phillip Kyriakakis exemplifies the spirit of innovation through his groundbreaking patents and contributions to science. His work continues to influence the fields of biosynthesis and nucleic acid technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
